novo tirzepatide F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Lilly's new drug Mounjaro (tirzepatide
Description
Obesity is a chronic disease, just like high blood pressure and diabetes
PlexusDx offers personalized tirzepatide options starting at $249/month with genetic insights to help minimize side effects
Growing research suggests prolonged GLP-1 use may be linked to bone density changes
Real results with physician-supervised care.
Novo cut Wegovy prices by 37%, signed second-brand partnerships with Abbott and Emcure to expand reach
Explore how Ozempic helps manage type 2 diabetes in Australia
